Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 15/20 | 0.52 |
| ▸ | CNR1 | P21554 | 9/20 | 0.52 |
| ▸ | THRB | P10828 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | APEX1 | P27695 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26772615 | 0.98 | CNR2 (0.52) | CNR2CNR1THRBMEN1APEX1 | |
| SCHEMBL9968788 | 0.95 | CNR2 (0.47) | CNR2CNR1THRBMEN1APEX1 | |
| SCHEMBL14499815 | 0.94 | THRB (0.53) | CNR2CNR1THRBMEN1APEX1 | |
| SCHEMBL9968786 | 0.91 | THRB (0.47) | CNR2CNR1THRBMEN1APEX1 | |
| SCHEMBL19650671 | 0.91 | CNR2 (0.52) | CNR2CNR1THRBMEN1APEX1 | |
| SCHEMBL13601252 | 0.91 | THRB (0.52) | CNR2CNR1THRBMEN1APEX1 | |
| SCHEMBL29231144 | 0.87 | CNR2 (0.55) | CNR2CNR1THRBMEN1APEX1 | |
| SCHEMBL18733755 | 0.87 | THRB (0.49) | CNR2CNR1THRBMEN1APEX1 | |
| SCHEMBL9968783 | 0.86 | SNCA (0.47) | CNR2CNR1THRBMEN1APEX1 | |
| SCHEMBL19428162 | 0.86 | THRB (0.49) | CNR2CNR1THRBMEN1APEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160348043-A1 | HIGH-EFFICIENCY PERFUME CAPSULES | PROCTER & GAMBLE (US) | 2016-12-01 | — | — | US | disclosed |
| US-9493730-B2 | Cleaning composition comprising amylase variants with high stability in the presence of a chelating agent | THE PROCTER & GAMBLE COMPANY (US) | 2016-11-15 | — | — | US | disclosed |
| US-20140249069-A1 | HIGH-EFFICIENCY PERFUME CAPSULES | THE PROCTER & GAMBLE COMPANY (US) | 2014-09-04 | — | — | US | disclosed |
| US-8785171-B2 | Fabric and home care products comprising cold water proteases | THE PROCTER & GAMBLE COMPANY (US) | 2014-07-22 | — | — | US | disclosed |
| US-20140193888-A1 | FABRIC AND HOME CARE PRODUCTS | THE PROCTER & GAMBLE COMPANY (US) | 2014-07-10 | — | — | US | disclosed |
| US-8759275-B2 | High-efficiency perfume capsules | THE PROCTOR & GAMBLE COMPANY (US) | 2014-06-24 | — | — | US | disclosed |
| US-8586521-B2 | Method of laundering fabrics at low temperature | THE PROCTER & GAMBLE COMPANY (US) | 2013-11-19 | — | — | US | disclosed |
| US-8449626-B2 | Cleaning method | THE PROCTER & GAMBLE COMPANY (US) | 2013-05-28 | — | — | US | disclosed |
| US-20120151684-A1 | METHOD OF LAUNDERING FABRICS AT LOW TEMPERATURE | PROCTER & GAMBLE COMPANY, THE | 2012-06-21 | — | — | US | disclosed |
| US-20110257065-A1 | Detergent Composition | THE PROCTER & GAMBLE COMPANY | 2011-10-20 | — | — | US | disclosed |
| US-20110237487-A1 | FABRIC AND HOME CARE PRODUCTS | THE PROCTER & GAMBLE COMPANY | 2011-09-29 | — | — | US | disclosed |
| US-20110212876-A1 | CLEANING COMPOSITION COMPRISING AMYLASE VARIANTS WITH HIGH STABILITY IN THE PRESENCE OF A CHELATING AGENT | THE PROCTER & GAMBLE COMPANY | 2011-09-01 | — | — | US | disclosed |
| US-20110195481-A1 | Variants And Compositions Comprising Variants With High Stability In Presence Of A Chelating Agent | NOVOZYMES A/S (DK) | 2011-08-11 | — | — | US | disclosed |
| US-20110107527-A1 | CLEANING METHOD | THE PROCTER & GAMBLE COMPANY | 2011-05-12 | — | — | US | disclosed |
| US-20110111999-A1 | HIGH-EFFICIENCY PERFUME CAPSULES | THE PROCTER & GAMBLE COMPANY | 2011-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110107527-A1 | CLEANING METHOD | CAT, MPO, LBR | CNR2 4683/4885CNR1 4641/4885THRB 4167/4885 |
| US-20110111999-A1 | HIGH-EFFICIENCY PERFUME CAPSULES | PLIN5, PORCN, PIGS | CNR2 549/4885CNR1 852/4885THRB 4809/4885 |
| US-20160348043-A1 | HIGH-EFFICIENCY PERFUME CAPSULES | PLIN5, PORCN, PIGS | CNR2 549/4885CNR1 852/4885THRB 4809/4885 |
| US-20110195481-A1 | Variants And Compositions Comprising Variants With High Stability In Presence Of A Chelating Agent | RNASE1, AMY2A, AMY1A | CNR2 4708/4885CNR1 4519/4885THRB 4235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.